Sarah Leigh Nicholson

1.7k total citations
12 papers, 1.0k citations indexed

About

Sarah Leigh Nicholson is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah Leigh Nicholson has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sarah Leigh Nicholson's work include Hedgehog Signaling Pathway Studies (4 papers), Glioma Diagnosis and Treatment (4 papers) and Neurological disorders and treatments (3 papers). Sarah Leigh Nicholson is often cited by papers focused on Hedgehog Signaling Pathway Studies (4 papers), Glioma Diagnosis and Treatment (4 papers) and Neurological disorders and treatments (3 papers). Sarah Leigh Nicholson collaborates with scholars based in United Kingdom, France and United States. Sarah Leigh Nicholson's co-authors include Jonathan M. Brotchie, Steven C. Clifford, David W. Ellison, Simon Bailey, Roger Taylor, Mehmet Koçak, James Dalton, Arie Perry, Charles H. Fraga and Richard J. Gilbertson and has published in prestigious journals such as Journal of Clinical Oncology, Experimental Neurology and Acta Neuropathologica.

In The Last Decade

Sarah Leigh Nicholson

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Leigh Nicholson United Kingdom	10	645	513	279	168	162	12	1.0k
Damien Faury Canada	15	504 0.8×	431 0.8×	222 0.8×	138 0.8×	62 0.4×	25	845
K. Rosanna United States	10	667 1.0×	224 0.4×	438 1.6×	143 0.9×	194 1.2×	13	1.1k
Atik Baborie United Kingdom	16	417 0.6×	466 0.9×	540 1.9×	134 0.8×	83 0.5×	33	1.1k
Viola Caretti United States	13	374 0.6×	456 0.9×	165 0.6×	149 0.9×	179 1.1×	17	1.0k
Wibke G. Janzarik Germany	9	418 0.6×	624 1.2×	360 1.3×	158 0.9×	63 0.4×	21	1.0k
Hitomi Tsuiji Japan	16	686 1.1×	214 0.4×	268 1.0×	162 1.0×	110 0.7×	21	969
Robert C. Castellino United States	21	901 1.4×	306 0.6×	128 0.5×	163 1.0×	193 1.2×	49	1.2k
Makoto Ideguchi Japan	16	575 0.9×	246 0.5×	206 0.7×	56 0.3×	326 2.0×	44	1.1k
Paula Ravin United States	10	284 0.4×	196 0.4×	187 0.7×	121 0.7×	129 0.8×	15	697
M. L. Bajenaru United States	11	502 0.8×	282 0.5×	475 1.7×	112 0.7×	133 0.8×	14	1.2k

Countries citing papers authored by Sarah Leigh Nicholson

Since Specialization

Citations

This map shows the geographic impact of Sarah Leigh Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Leigh Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Leigh Nicholson more than expected).

Fields of papers citing papers by Sarah Leigh Nicholson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Leigh Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Leigh Nicholson. The network helps show where Sarah Leigh Nicholson may publish in the future.

Co-authorship network of co-authors of Sarah Leigh Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Leigh Nicholson. A scholar is included among the top collaborators of Sarah Leigh Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Leigh Nicholson. Sarah Leigh Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Crosier, Stephen, Debbie Hicks, Ed C. Schwalbe, et al.. (2021). Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics. Neuropathology and Applied Neurobiology. 47(6). 736–747. 8 indexed citations

Bundred, Nigel, et al.. (2020). Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion. Cancer Medicine. 9(5). 1768–1778. 23 indexed citations

Clifford, Steven C., Birgitta Lannering, Ed C. Schwalbe, et al.. (2015). Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial. Oncotarget. 6(36). 38827–38839. 38 indexed citations

Yasin, Shireena A., Mathew Tata, Simon Picker, et al.. (2013). mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathologica. 126(2). 207–218. 65 indexed citations

Ryan, Sarra, Ed C. Schwalbe, Michael Cole, et al.. (2011). MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathologica. 123(4). 501–513. 65 indexed citations

Nicholson, Sarah Leigh, et al.. (2011). Yin Yang 1 in Human Cancer. Critical Reviews™ in Oncogenesis. 16(3-4). 245–260. 40 indexed citations

Ellison, David W., James Dalton, Mehmet Koçak, et al.. (2011). Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica. 121(3). 381–396. 377 indexed citations

Ellison, David W., Mehmet Koçak, James Dalton, et al.. (2010). Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables. Journal of Clinical Oncology. 29(11). 1400–1407. 203 indexed citations

Silverdale, Monty, Sarah Leigh Nicholson, Alan R. Crossman, & Jonathan M. Brotchie. (2004). Topiramate reduces levodopa‐induced dyskinesia in the MPTP‐lesioned marmoset model of Parkinson's disease. Movement Disorders. 20(4). 403–409. 48 indexed citations

10.

Silverdale, Monty, Sarah Leigh Nicholson, Paula Ravenscroft, et al.. (2004). Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate. Experimental Neurology. 188(1). 128–138. 43 indexed citations

11.

Nicholson, Sarah Leigh & Jonathan M. Brotchie. (2002). 5‐hydroxytryptamine (5‐HT, serotonin) and Parkinson's disease – opportunities for novel therapeutics to reduce the problems of levodopa therapy. European Journal of Neurology. 9(s3). 1–6. 108 indexed citations

12.

Nicholson, Sarah Leigh & Jonathan Waxman. (1997). Prostate cancer and endocrine therapy. Endocrine Related Cancer. 4(2). 141–152. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact